Skip to main content

CORRECTION article

Front. Pharmacol., 05 January 2022
Sec. Respiratory Pharmacology
This article is part of the Research Topic Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases View all 20 articles

Corrigendum: The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook

Mingyao LuoMingyao Luo1Mingyuan Du,Mingyuan Du2,3Chang Shu,,Chang Shu1,2,3Sheng LiuSheng Liu1Jiehua Li,Jiehua Li2,3Lei Zhang,Lei Zhang2,3Xin Li,
Xin Li2,3*
  • 1State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
  • 2Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
  • 3The Institute of Vascular Diseases, Central South University, Changsha, China

A Corrigendum on
The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook

by Luo, M., Du, M., Shu, C., Liu, S., Li, J., Zhang, L., and Li, X. (2021). Front. Pharmacol. 12:743945. doi: 10.3389/fphar.2021.743945

In the original article, there was a mistake in the caption for Figure 1A as published. The corrected sentence in the caption reads as follows: “(A) inflammatory intima specimen accompanied with emboli in pulmonary artery main trunk (black arrow) taken from a patient of pulmonary vasculitis.” The corrected Figure 1 appears below.

FIGURE 1
www.frontiersin.org

FIGURE 1. Human pulmonary artery pathological specimen shows (A) inflammatory intima specimen accompanied with emboli in pulmonary artery main trunk (black arrow) taken from a patient of pulmonary vasculitis; (B) hyperplasia endothelial tissue from pulmonary endarterectomy operation in chronic thrombosis embolic pulmonary hypertension (CTEPH) patient.

The authors apologize for this error and state that it does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: biomarker, deep venous thrombosis, miRNA, molecular regulation, pulmonary embolism, treatment target

Citation: Luo M, Du M, Shu C, Liu S, Li J, Zhang L and Li X (2022) Corrigendum: The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook. Front. Pharmacol. 12:822059. doi: 10.3389/fphar.2021.822059

Received: 25 November 2021; Accepted: 07 December 2021;
Published: 05 January 2022.

Edited and reviewed by:

Xiaohui Li, Central South University, China

Copyright © 2022 Luo, Du, Shu, Liu, Li, Zhang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xin Li, lixin1981@csu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.